HPI - Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net income		$ 100,000	$ 27,213
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		71,405	73,671
Amortization of lease incentives and acquisition-related intangible assets and liabilities		491	351
Share-based compensation expense		4,967	4,833
Net credit losses/(reversals) on operating lease receivables		556	(140)
Accrued interest on mortgages and notes receivable		(178)	(125)
Amortization of debt issuance costs		1,404	1,381
Amortization of cash flow hedges		(62)	(62)
Amortization of mortgages and notes payable fair value adjustments		28	28
Losses on debt extinguishment		0	173
Net gains on disposition of property		(82,215)	(7,209)
Equity in earnings of unconsolidated affiliates		(1,315)	(654)
Distributions of earnings from unconsolidated affiliates		1,942	977
Changes in operating assets and liabilities:
Accounts receivable		1,587	(3,651)
Prepaid expenses and other assets		(2,092)	(2,116)
Accrued straight-line rents receivable		(3,144)	(3,218)
Accounts payable, accrued expenses and other liabilities		(47,050)	(19,042)
Net cash provided by operating activities		46,324	72,410
Investing activities:
Investments in acquired real estate and related intangible assets, net of cash acquired		(137,828)	0
Investments in development in-process		0	(2,558)
Investments in tenant improvements and deferred leasing costs		(25,304)	(29,088)
Investments in building improvements		(11,038)	(8,989)
Net proceeds from disposition of real estate assets		137,779	16,249
Distributions of capital from unconsolidated affiliates		941	963
Investments in mortgages and notes receivable		(1,577)	(6,229)
Repayments of mortgages and notes receivable		6,320	16
Investments in and advances to unconsolidated affiliates		(8,191)	(30,869)
Changes in earnest money deposits		10,000	0
Changes in other investing activities		1,689	(1,180)
Net cash used in investing activities		(27,209)	(61,685)
Financing activities:
Dividends on Common Stock		(53,820)	(52,871)
Redemptions of Common Units		(10)	0
Dividends on Preferred Stock		(621)	(621)
Distributions to noncontrolling interests in the Operating Partnership		(1,076)	(1,076)
Distributions to noncontrolling interest in consolidated affiliates		(80)	0
Proceeds from the issuance of Common Stock		411	363
Costs paid for the issuance of Common Stock		(164)	0
Repurchase of shares related to tax withholdings		(2,009)	(1,427)
Borrowings on revolving credit facility		185,000	75,000
Repayments of revolving credit facility		(139,000)	(25,000)
Repayments of mortgages and notes payable		(1,909)	(1,727)
Payments for debt issuance costs and other financing activities		0	(7,648)
Net cash used in financing activities		(13,278)	(15,007)
Net increase/(decrease) in cash and cash equivalents and restricted cash		5,837	(4,282)
Cash and cash equivalents and restricted cash at beginning of the period		33,677	31,569
Cash and cash equivalents and restricted cash at end of the period		39,514	27,287
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents at end of the period		20,107	16,422
Restricted cash at end of the period		19,407	10,865
Supplemental disclosure of cash flow information:
Cash paid for interest, net of amounts capitalized		50,530	36,772
Supplemental disclosure of non-cash investing and financing activities:
Conversions of Common Units to Common Stock		0	132
Changes in accrued capital expenditures	[1]	(4,059)	5,734
Write-off of fully depreciated real estate assets		34,243	19,549
Write-off of fully amortized leasing costs		18,674	4,691
Write-off of fully amortized debt issuance costs		0	4,083
Adjustment of noncontrolling interests in the Operating Partnership to fair value		(2,902)	7,479
Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities		$ 48,800	$ 61,300

[1] Accrued capital expenditures included in accounts payable, accrued expenses and other liabilities as of March 31, 2025 and 2024 were $48.8 million and $61.3 million, respectively.